Todd M. Pitts

Also affiliated with University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, University of Colorado Denver

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 22 papers. Top paper: “Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics data”.

Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics data

Nature Computational Science(2024)10.1038/s43588-024-00597-5

N/A

0.617DataRank · unranked

17 citations

Anna Capasso, S. Gail Eckhardt, Uma Giri, Alexander Somma, Todd M. Pitts +9 more

First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0106

N/A

0.510DataRank · unranked

29 citations

Qiong Zhou, Hector Esquer, Laura A. Pike, Travis P. Broneske, Sébastien Rinaldetti +10 more

Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0065

N/A

0.488DataRank · unranked

16 citations

Adrian T.A. Dominguez, Shaikh M. Atif, Alberto Dinarello, Tania Azam, Kibrom M. Alula +11 more

Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer

Cancers(2020)10.3390/cancers12030719

N/A

0.483DataRank · unranked

24 citations

Dennis M. Simmons, Stacey M. Bagby, Sarah J. Hartman, Betelehem W. Yacob, Brian Gittleman +7 more

Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0455

N/A

0DataRank · unranked

25 citations

Todd M. Pitts, Dana Ungermannova, Christopher G. Nasveschuk, Gan Zhang, Andrew J. Phillips +15 more

WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma

Frontiers in Oncology(2021)10.3389/fonc.2021.642328

N/A

0DataRank · unranked

30 citations

Stacey M. Bagby, Betelehem W. Yacob, Dennis M. Simmons, Morgan MacBeth, Christopher H. Lieu +8 more

Modulating Enzyme Function via Dynamic Allostery within Biliverdin Reductase B

Frontiers in Molecular Biosciences(2021)10.3389/fmolb.2021.691208

N/A

0DataRank · unranked

9 citations

Michael R. Duff, Ashley Blue, Todd M. Pitts, Pratul K. Agarwal, Elan Eisenmesser +1 more

Endogenous retroviruses mediate transcriptional rewiring in response to oncogenic signaling in colorectal cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.28.466196

N/A

0DataRank · unranked

6 citations

David Simpson, Olivia Joyner, Stacey M. Bagby, Lily L. Nguyen, Benjamin G. Bitler +3 more

Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models

Frontiers in Oncology(2022)10.3389/fonc.2022.877635

N/A

0DataRank · unranked

16 citations

Alexis D. Leal, Juan A. Marín‐Jiménez, Sarah J. Hartman, Jeremy Shulman, Natalie M. Navarro +14 more

Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics data

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.20.524974

N/A

0DataRank · unranked

2 citations

Anna Capasso, S. Gail Eckhardt, Uma Giri, Alexander Somma, Todd M. Pitts +9 more

Trial in progress: A phase II study (with safety run-in) of evorpacept (ALX148), cetuximab, and pembrolizumab in patients with refractory microsatellite-stable metastatic colorectal cancer (AGICC-ALX148 21CRC01).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps257

N/A

0DataRank · unranked

0 citations

Junxiao Hu, Patrick J. Blatchford, Todd M. Pitts, Alexis D. Leal, Sunnie S. Kim +7 more

Data from Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors

(2023)10.1158/1535-7163.c.6543273.v1

N/A

0DataRank · unranked

0 citations

Todd M. Pitts, Dana Ungermannova, Christopher G. Nasveschuk, Gan Zhang, Andrew J. K. Phillips +15 more

Data from Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors

(2023)10.1158/1535-7163.c.6543273

N/A

0DataRank · unranked

0 citations

Todd M. Pitts, Dana Ungermannova, Christopher G. Nasveschuk, Gan Zhang, Andrew J. K. Phillips +15 more

Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis

Breast Cancer Research(2024)10.1186/s13058-024-01799-5

N/A

0DataRank · unranked

29 citations

Anna Schreiber, Marilyn M. Jackson, Stacey M. Bagby, Adrian T A. Dominguez, Evan D. Dus +6 more

A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0090

N/A

0DataRank · unranked

9 citations

Tyler J. Friedrich, Patrick J. Blatchford, Kimberly R. Jordan, Todd M. Pitts, Hannah R. Robinson +13 more

Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling

International Journal of Cancer(2024)10.1002/ijc.35087

N/A

0DataRank · unranked

5 citations

Robert J. Van Gulick, William A. Robinson, Tariq I. Mughal, Richard P. Tobin, Morgan MacBeth +22 more

Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL)

PLoS ONE(2024)10.1371/journal.pone.0298808

N/A

0DataRank · unranked

8 citations

Betelehem W. Yacob, Monica E. Brown, Brandon R. Goldstein, John J. Arcaroli, Stacey M. Bagby +11 more

Results of a phase 2 study of evorpacept (E, ALX148), cetuximab (C), and pembrolizumab (P) in patients with refractory microsatellite stable metastatic colorectal cancer (MSS CRC).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.3530

N/A

0DataRank · unranked

1 citations

Patrick J. Blatchford, Junxiao Hu, Todd M. Pitts, Adrie Van Bokhoven, Hannah R. Robinson +13 more

Pathological findings of immunotherapy-induced nephrotoxicity in a humanized immune system mouse model

Kidney International(2025)10.1016/j.kint.2025.01.021

N/A

0DataRank · unranked

5 citations

Lauren Thompson, Michael Goedken, Scott Lucia, Adrian T A. Dominguez, Adwitiya Kar +6 more

RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer

BMC Cancer(2020)10.1186/s12885-020-07500-1

N/A

0DataRank · unranked

30 citations

Julie Lang, Anna Capasso, Deog Joong Kim, Ely Benaim, Young Bok Lee +10 more

Results from the safety lead-in for a phase II study of pembrolizumab in combination with binimetinib and bevacizumab in patients with refractory metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4031

N/A

0DataRank · unranked

8 citations

S. Lindsey Davis, Stephen Leong, Alexis D. Leal, Patrick J. Blatchford, Gurprataap Singh Sandhu +15 more

Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes

Frontiers in Immunology(2021)10.3389/fimmu.2021.607282

N/A

0DataRank · unranked

50 citations

Anna Capasso, Matthew S. Lewis, Stacey M. Bagby, Sarah J. Hartman, Jeremy Shulman +26 more